BRENDAN RUDDY: Open Payments
NPI 1346945656 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 110 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $368 · 2025 $2,301
Food & beverage: $2,301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $547 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $433 |
| Janssen Pharmaceuticals, Inc | 13 | $428 |
| Alkermes, Inc. | 7 | $187 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| Teva Pharmaceuticals USA, Inc. | 5 | $103 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 5 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, SPRAVATO, REXULTI, ARISTADA, Auvelity, INGREZZA.
Industry payments across NY — which companies pay providers there.
